De Lemos-Bonotto M et al. |
A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment. |
2018 |
Eur J Gastroenterol Hepatol |
pmid:29227329
|
Watanabe N et al. |
The possible clinical impact of risperidone on P-glycoprotein-mediated transport of tacrolimus: A case report and in vitro study. |
2018 |
Biopharm Drug Dispos |
pmid:29055041
|
Sakai R et al. |
Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan. |
2018 |
Lupus |
pmid:28683654
|
Almeida-Paulo GN et al. |
Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplant. |
2018 |
Pharmacogenomics J. |
pmid:28094348
|
Wang DD et al. |
Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study. |
2018 |
J Clin Pharm Ther |
pmid:29766530
|
Nakagita K et al. |
Effect of fluconazole on the pharmacokinetics of everolimus and tacrolimus in a heart transplant recipient: Case report. |
2018 |
Int J Clin Pharmacol Ther |
pmid:29648533
|
Takeuchi K et al. |
Comparison of Safety and Efficacy of Tacrolimus versus Infliximab for Active Ulcerative Colitis. |
2018 |
Dig Dis |
pmid:29050007
|
Mashiah J et al. |
Topical pimecrolimus for paediatric cutaneous mastocytosis. |
2018 |
Clin. Exp. Dermatol. |
pmid:29460435
|
Costa D et al. |
Human cryptosporidiosis in immunodeficient patients in France (2015-2017). |
2018 |
Exp. Parasitol. |
pmid:30107154
|
Dheer D et al. |
Tacrolimus: An updated review on delivering strategies for multifarious diseases. |
2018 |
Eur J Pharm Sci |
pmid:29277665
|